Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bazhen Liquid is a traditional Chinese medicine (TCM) oral liquid formulation developed and manufactured by Guangdong Wannianqing Pharmaceutical. It is based on the classic "Eight Treasures" (Bazhen) decoction, a combination of eight medicinal herbs designed to tonify both Qi and Blood. The formulation typically includes *Panax ginseng*, *Atractylodes macrocephala*, *Poria cocos*, *Glycyrrhiza uralensis*, *Rehmannia glutinosa*, *Angelica sinensis*, *Paeonia lactiflora*, and *Ligusticum chuanxiong*. It is primarily indicated for the treatment of Qi and Blood deficiency, characterized by symptoms such as dizziness, fatigue, loss of appetite, and a sallow or pale complexion. As a liquid formulation, it is designed for ease of administration and rapid absorption compared to traditional pill or decoction forms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bazhen Liquid.